The STOP-NIDDM trial: An international study on the efficacy of an α- glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
Jean Louis Chiasson*, Ramon Gomis, Markolf Hanefeld, Robert G. Josse, Avraham Karasik, Markku Laakso
Research output: Contribution to journal › Article › peer-review
190Scopus
citations
Fingerprint
Dive into the research topics of 'The STOP-NIDDM trial: An international study on the efficacy of an α- glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data'. Together they form a unique fingerprint.